NOKOMIS, Fla.--(BUSINESS WIRE)--As emerging biotech firm Rainbow Biosciences, LLC, a subsidiary of Rainbow Coral Corp. (OTCBB:RBCC), closes in on a deal with a new clinical-stage company developing diagnostics and therapeutics for Parkinson’s disease, the illness’ commonalities with Alzheimer’s disease could potentially lead to an even larger market for new therapies.
